Mizuho analyst Vikram Malhotra downgraded Medical Properties Trust to Neutral from Buy with a price target of $9, down from $18. The analyst cites near-term earnings dilution and an “elongated recovery path” for the downgrade. Management’s attempt to reduce leverage via asset sales will likely be earnings dilutive, the analyst tells investors in a research note. The firm says Medical Properties’ key hospital tenants remain challenged and additional clarity will take time.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MPW:
- Trouble Ahead for Medical Properties Trust? (NYSE:MPW)
- Medical Properties Trust Stock (NYSE:MPW): Short-Term Pain for Long-Term Gains
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Medical Properties Stock (NYSE:MPW): The Dividend Cut is Actually Bullish
- Unusually active option classes on open August 23rd